LifeMD (LFMD) News Today $5.42 -0.14 (-2.52%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Royce & Associates LP Has $4.72 Million Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD)Royce & Associates LP lifted its holdings in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 901,041 shares of the company's stNovember 19 at 4:33 AM | marketbeat.comLos Angeles Capital Management LLC Acquires 108,822 Shares of LifeMD, Inc. (NASDAQ:LFMD)Los Angeles Capital Management LLC boosted its position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 852.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 121,585 shares of the company's stock afteNovember 17, 2024 | marketbeat.comLifeMD (LFMD) Gets a Buy from Craig-HallumNovember 15, 2024 | markets.businessinsider.comLifeMD (NASDAQ:LFMD) Earns "Buy" Rating from HC WainwrightNovember 13, 2024 | americanbankingnews.comLifeMD to Participate in Three Investor Conferences During NovemberNovember 12, 2024 | markets.businessinsider.comStrong Revenue Growth and Strategic Initiatives Position LifeMD for Continued Expansion Despite ChallengesNovember 11, 2024 | markets.businessinsider.comLifeMD, Inc.: LifeMD Reports Third Quarter 2024 ResultsNovember 11, 2024 | finanznachrichten.deLifeMD (NASDAQ:LFMD) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $12.00 price target on shares of LifeMD in a report on Monday.November 11, 2024 | marketbeat.comLifeMD, Inc. (LFMD) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comLifeMD backs FY24 revenue view at least $205M, consensus $206MNovember 9, 2024 | markets.businessinsider.comLifeMD price target raised to $12 from $11 at B. RileyNovember 9, 2024 | markets.businessinsider.comLifeMD Reports Third Quarter 2024 ResultsNovember 7, 2024 | globenewswire.comLifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational EfficiencyNovember 6, 2024 | markets.businessinsider.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Buy" from BrokeragesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has received a consensus rating of "Buy" from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts thaNovember 2, 2024 | marketbeat.comLifeMD (LFMD) Scheduled to Post Quarterly Earnings on ThursdayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639696)October 31, 2024 | marketbeat.comLifeMD launches TestoRx, direct to consumer testosterone replacement therapyOctober 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for LifeMD Amid Favorable Compounding Pharmacy Developments and Strong Market PositioningOctober 15, 2024 | markets.businessinsider.comLifeMD Inc (LFMD) Q2 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ...October 9, 2024 | finance.yahoo.comLifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockSeptember 24, 2024 | globenewswire.comLifeMD, Inc. (LFMD)September 22, 2024 | finance.yahoo.comLifeMD (NASDAQ:LFMD) Given "Overweight" Rating at Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and issued a $15.00 price objective on shares of LifeMD in a report on Friday.September 20, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Shares Sold by Divisadero Street Capital Management LPDivisadero Street Capital Management LP cut its position in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 11.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,498,382 shares of the company's stock after selliSeptember 20, 2024 | marketbeat.comInsider Buying: LifeMD, Inc. (NASDAQ:LFMD) Insider Buys 3,000 Shares of StockSeptember 13, 2024 | insidertrades.comLifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Buy" by BrokeragesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages thSeptember 13, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Insider Stefan Galluppi Buys 3,000 SharesLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) insider Stefan Galluppi acquired 3,000 shares of the firm's stock in a transaction dated Wednesday, September 11th. The shares were purchased at an average cost of $4.93 per share, with a total value of $14,790.00. Following the completion of the transaction, the insider now owns 45,449 shares in the company, valued at approximately $224,063.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.September 12, 2024 | marketbeat.comLifeMD to Participate in Three Investor Conferences During SeptemberAugust 26, 2024 | globenewswire.comCalamos Advisors LLC Acquires Shares of 57,413 LifeMD, Inc. (NASDAQ:LFMD)Calamos Advisors LLC bought a new position in shares of LifeMD, Inc. (NASDAQ:LFMD - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 57,413 shares of the company's stock, valued at approximatelyAugust 26, 2024 | marketbeat.comLifeMD's (LFMD) "Overweight" Rating Reaffirmed at Cantor FitzgeraldCantor Fitzgerald reaffirmed an "overweight" rating and set a $15.00 target price on shares of LifeMD in a research report on Tuesday.August 20, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Buy" from AnalystsLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a buy rating. The average twelve-month price target among analystsAugust 19, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Short Interest Up 12.9% in JulyLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 4,450,000 shares, a growth of 12.9% from the July 15th total of 3,940,000 shares. Currently, 13.2% of the company's shares are sold short. Based on an average daily volume of 895,300 shares, the short-interest ratio is presently 5.0 days.August 18, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. raised its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 12.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,155,193 shares of the company's stock after acquiring an additional 128,701 shares during the quarAugust 14, 2024 | marketbeat.comLifeMD (NASDAQ:LFMD) Earns "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $15.00 price target on shares of LifeMD in a report on Friday.August 9, 2024 | marketbeat.comLifeMD’s Consistent Growth and Margin Improvement Reinforce Buy RatingAugust 8, 2024 | markets.businessinsider.comStrong Growth and Positive Outlook Justify Buy Rating for LifeMDAugust 8, 2024 | markets.businessinsider.comLifeMD Inc LFMDAugust 2, 2024 | morningstar.comLifeMD (LFMD) Scheduled to Post Earnings on WednesdayLifeMD (NASDAQ:LFMD) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.July 31, 2024 | marketbeat.comAcadian Asset Management LLC Boosts Stock Position in LifeMD, Inc. (NASDAQ:LFMD)Acadian Asset Management LLC boosted its holdings in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 261.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 116,655 shares of the company's stock after buying an additionalJuly 26, 2024 | marketbeat.comCan the New CEO Revive This Struggling Telehealth Stock? (LFMD)Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023July 24, 2024 | marketbeat.com3 Overlooked Telehealth Stocks Poised for a ComebackJuly 16, 2024 | investorplace.comLifeMD (NASDAQ:LFMD) Given New $10.00 Price Target at KeyCorpKeyCorp decreased their price objective on LifeMD from $12.00 to $10.00 and set an "overweight" rating for the company in a report on Thursday.July 11, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by BrokeragesShares of LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) have received an average recommendation of "Buy" from the six ratings firms that are presently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating. The average 1-year price objective among bJune 30, 2024 | marketbeat.comLifeMD, Inc. (NASDAQ:LFMD) Short Interest UpdateLifeMD, Inc. (NASDAQ:LFMD - Get Free Report) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 3,270,000 shares, a growth of 30.3% from the May 31st total of 2,510,000 shares. Currently, 10.0% of the company's stock are sold short. Based on an average daily volume of 786,200 shares, the days-to-cover ratio is currently 4.2 days.June 29, 2024 | marketbeat.comLifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred StockJune 25, 2024 | globenewswire.comLifeMD, Inc. (NASDAQ:LFMD) Shares Purchased by G2 Investment Partners Management LLCG2 Investment Partners Management LLC grew its position in LifeMD, Inc. (NASDAQ:LFMD - Free Report) by 23.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 688,050 shares of the company's stock after purchasing an aJune 13, 2024 | marketbeat.comLifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health SummitJune 10, 2024 | globenewswire.comLifeMD (NASDAQ:LFMD) Coverage Initiated at KeyCorpKeyCorp started coverage on shares of LifeMD in a research note on Wednesday. They issued an "overweight" rating and a $12.00 target price for the company.June 5, 2024 | marketbeat.comHims & Hers Health Soars on Generic GLP-1 Rollout Plans (LFMD)Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatmentsJune 3, 2024 | marketbeat.comLifeMD Set to Join the Russell 3000 IndexMay 29, 2024 | finance.yahoo.comLifeMD Can Surge on Its GLP-1 Offerings LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a resultMay 28, 2024 | marketbeat.comLifeMD Can Surge on Its GLP-1 OfferingsLifeMD Inc. NASDAQ: LFMD is a leading telehealth provider operating an end-to-end virtual healthcare platform. LifeMD operates a direct-to-consumer (DTC) model focused on offering on-demand primary care services to consumers.May 28, 2024 | marketbeat.com Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. LFMD Media Mentions By Week LFMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFMD News Sentiment▼0.870.45▲Average Medical News Sentiment LFMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFMD Articles This Week▼32▲LFMD Articles Average Week Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regis News Today MEDIROM Healthcare Technologies News Today Castle Biosciences News Today agilon health News Today InnovAge News Today Sharecare News Today Fulgent Genetics News Today Auna News Today Grail News Today Celcuity News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFMD Stock Alerts